Study details
Enrolling now
Pramipexole to Enhance Social Connections
University of California, San Diego
NCT IDNCT06269146ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
108
Study length
about 1.9 years
Ages
18–50
Locations
2 sites in CA, NY
About this study
This trial is testing if pramipexole, a medication, can improve social connectedness in adults experiencing anxiety or depression. Participants will take either a placebo pill or pramipexole for 687 days. It aims to understand how pramipexole affects brain function and behavior related to social reward processing.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Placebo Pill
- 2.Take Pramipexole Pill
PhasePhase 2
DrugPramipexole Pill
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low10%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
NERVOUS SYSTEM
Drug routes
oral
Body systems
Psychiatry / Mental Health